
    
      Prospective 7-year randomised investigator -masked clinical trial 79 eyes (79 patients)
      enrolled randomised to surgery by PEX and previous pilocarpine use Deep sclerectomy n = 41
      Trabeculectomy n = 38 Estimated DS : TE success = 1:3 10% attrition ; power = 90%, alpha = 5%

      Methods and evaluation of outcomes:

        1. IOP: average of the two highest readings of the IOP phasing (6 readings)

        2. VA: LogMAR (ETDRS chart)

        3. Lens: LOCSII (slit lamp classification), worsening = one step progression confirmed at
           two visits

      study visits: every 4 months
    
  